Abstract
Abstract: Background: During the last decades, Solid Lipid Nanoparticles (SLNs) have attracted the interest of many researchers and have been utilized as delivery systems in an increasing number of applications.
Methods: This delivery system has shown potential as alternative drug delivery system as compared to various other oral particulate delivery systems. The lipids used in the formulations are biodegradable, biocompatible, and physiological lipids, so there may be less toxicity problems related with this dosage form.
Results: It can encapsulate both hydrophilic and hydrophobic drugs with prolonged release pattern. The main advantage of lipid-based systems is to improve gastrointestinal (GI) absorption and oral bioavailability of many lipophilic drugs. SLN showed improved physical stability, prevent enzymatic degradation, high drug loading and prolonged release of incorporated drugs. The stability of the formulations might increase than other liquid nanocarriers due to the solid matrix of these lipid nanoparticles. SLN showed improved bioavailability of several drugs by increasing the oral absorption.
Conclusion: In this review, oral bioavailability enhancement mechanisms, recent patents and advances in oral delivery of the solid lipid nanoparticles based on solid matrix will be discussed.
Keywords: Bioavailability, formulation technique, homogenization, microemulsion, nanoparticles.
Current Nanomedicine
Title:Solid Lipid Nanoparticles: Special Feature, Bioavailability Enhancement and Recent Advances in the Oral Drug Delivery
Volume: 6 Issue: 1
Author(s): Syed S. Imam, Mohammed Aqil and Yasmin Sultana
Affiliation:
Keywords: Bioavailability, formulation technique, homogenization, microemulsion, nanoparticles.
Abstract: Abstract: Background: During the last decades, Solid Lipid Nanoparticles (SLNs) have attracted the interest of many researchers and have been utilized as delivery systems in an increasing number of applications.
Methods: This delivery system has shown potential as alternative drug delivery system as compared to various other oral particulate delivery systems. The lipids used in the formulations are biodegradable, biocompatible, and physiological lipids, so there may be less toxicity problems related with this dosage form.
Results: It can encapsulate both hydrophilic and hydrophobic drugs with prolonged release pattern. The main advantage of lipid-based systems is to improve gastrointestinal (GI) absorption and oral bioavailability of many lipophilic drugs. SLN showed improved physical stability, prevent enzymatic degradation, high drug loading and prolonged release of incorporated drugs. The stability of the formulations might increase than other liquid nanocarriers due to the solid matrix of these lipid nanoparticles. SLN showed improved bioavailability of several drugs by increasing the oral absorption.
Conclusion: In this review, oral bioavailability enhancement mechanisms, recent patents and advances in oral delivery of the solid lipid nanoparticles based on solid matrix will be discussed.
Export Options
About this article
Cite this article as:
Imam S. Syed, Aqil Mohammed and Sultana Yasmin, Solid Lipid Nanoparticles: Special Feature, Bioavailability Enhancement and Recent Advances in the Oral Drug Delivery, Current Nanomedicine 2016; 6(1) . https://dx.doi.org/10.2174/1877912305666151012194404
DOI https://dx.doi.org/10.2174/1877912305666151012194404 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Natural Products from Plants as Drug Candidates and Lead Compounds Against Leishmaniasis and Trypanosomiasis
Current Medicinal Chemistry Hormonal Control of the Neuropeptide Y System
Current Protein & Peptide Science Methodologies to Assess Brain Drug Delivery in Lead Optimization
Current Topics in Medicinal Chemistry Efficacy of Fluoroquinolones Against Pathogenic Oral Bacteria
Mini-Reviews in Medicinal Chemistry Tangier Disease Four Decades of Research: A Reflection of the Importance of HDL
Current Medicinal Chemistry Type 2 Diabetes Mellitus with Early Dry Skin Disorder: A Comparison Study Between Primary and Tertiary Care in Indonesia
Current Diabetes Reviews Subject Index to Volume 11
Current Medicinal Chemistry Mannose-Binding Lectin Protein Deficiency Among Patients with Primary Immunodeficiency Disease Receiving IVIG Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Can Diet and Physical Activity Limit Alzheimer's Disease Risk?
Current Alzheimer Research The Use of Herbal Medicine in Cancer-related Anorexia/ Cachexia Treatment Around the World
Current Pharmaceutical Design State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
Recent Patents on Anti-Cancer Drug Discovery A Progressive Review of V600E-B-RAF-Dependent Melanoma and Drugs Inhibiting It
Mini-Reviews in Medicinal Chemistry Screening for Liver Disease - are LFTs Old HAT?
Current Medicinal Chemistry Glycosphingolipid Clusters as Organizers of Plasma Membrane Rafts and Caveolae
Current Organic Chemistry The Influence of Tetracycline Inducible Targeting Rat PPARγ Gene Silencing on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells
Current Pharmaceutical Design Understanding Heterogeneity in Supplementation Effects of Selenium in Men: A Study of Stratification Variables and Human Genetics in a Prospective Sample from New Zealand
Current Pharmacogenomics and Personalized Medicine Spectral Methods of Characterizing the Conformational Changes of Glycated Goat Liver Cystatin
Current Proteomics Nutraceuticals, A New Challenge for Medicinal Chemistry
Current Medicinal Chemistry Genetic and Pharmacological Modulation of Dendritic Cell-T Cell Interactions as a Therapeutic Strategy for Systemic Lupus Erythematosus
Current Gene Therapy New Antipsychotics in Treatment of Mood Instability and Cognitive Perceptual Symptoms in Borderline Personality Disorder
Current Psychopharmacology